governmentFilingsNewsغير مصنف

UPDATE 2-Glaxo evaluating possibility of using vaccine technology for Zika

Jan 25 (Reuters) – GlaxoSmithKline Plc is
concluding feasibility studies evaluating whether its vaccine
technology is suitable for the Zika virus, which has been linked
to brain damage in thousands…

اظهر المزيد

مقالات ذات صلة

زر الذهاب إلى الأعلى